Oct 13, 6:14 AM ET
UnitedHealth Group reported third quarter 2026 diluted earnings of $4.56 per share, up from $2.59 a year earlier, on revenues of $112.7 billion, down slightly from $113.2 billion. The company raised its full-year 2026 outlook to at least $20.50 per share in adjusted earnings, which matters to shareholders because profit rose while the outlook improved.
- Diluted EPS was $4.56 versus $2.59 in Q3 2025; adjusted EPS was $4.69 versus $2.92.
- Earnings from operations were $6.6 billion versus $4.3 billion; revenues were $112.7 billion versus $113.2 billion.
- Full-year 2026 outlook: at least $19.50 per share in diluted earnings and at least $20.50 per share in adjusted earnings.
- Medical care ratio was 88.4% versus 89.9% a year earlier; debt-to-capital ratio was 41.7% as of September 30, 2026.
Read the filing on SEC.gov ↗
Sep 8, 4:04 PM ET
UnitedHealth Group announced that senior leaders will take part in an interview-format discussion at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, starting at 8:00 a.m. Eastern Time. The discussion will cover strategy, market positions, recent results and expectations for its end markets, and a live audio webcast will be available on the company's Investor Relations page.
- Presentation at Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, beginning 8:00 a.m. Eastern Time
- Topics include strategy, market positions, recent results and expectations for end markets
- Live audio webcast available through the Investor Relations page at www.unitedhealthgroup.com
Read the filing on SEC.gov ↗
Jul 16, 6:00 AM ET
UnitedHealth Group reported second quarter 2026 revenue of $112.0 billion, up from $111.6 billion a year earlier, and diluted earnings of $6.04 per share, up from $3.74. The company raised its full-year 2026 adjusted earnings outlook to $19.50 to $20.00 per share from $17.75 as of January 27, 2026, which signals higher expected profit for shareholders.
- Q2 2026 earnings from operations were $8.0 billion, compared with $5.2 billion in Q2 2025.
- Diluted EPS was $6.04 versus $3.74 a year earlier; adjusted EPS was $6.38 versus $4.08.
- Full-year 2026 adjusted EPS outlook raised to $19.50 to $20.00; diluted EPS outlook set at $18.45 to $18.95.
- Medical care ratio was 86.7% versus 89.4% in Q2 2025; the company has repurchased $4.0 billion of stock through mid-July 2026 and expects at least $5.0 billion for the year.
Read the filing on SEC.gov ↗
May 11, 5:28 PM ET
UnitedHealth Group's senior leaders will take part in an interview-format discussion at the Bank of America Securities Health Care Conference 2026 on May 12, 2026, starting at 11:00 a.m. Eastern Time. The filing says topics may include strategy, market positions, recent results and expectations for its end markets, and a live audio webcast will be posted on the company's Investor Relations page. The filing contains no new financial figures, so it is an administrative notice rather than a results or guidance update.
- Event: Bank of America Securities Health Care Conference 2026, interview format
- Date and time: Tuesday, May 12, 2026, beginning 11:00 a.m. Eastern Time
- Live audio webcast available through the Investor Relations page at www.unitedhealthgroup.com
- Filing contains no new financial results or guidance figures
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
